Lewis Antwi InspectorProfile


This InspectorProfile is a report of relevant audit-related information on Lewis Antwi, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Biologics.

Product Description

This InspectorProfile report is updated through and lists Lewis Antwi's 115 inspections in 1 countries: and United States.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Lewis Antwi's inspection information so that you can mitigate investigator-related risks.

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Lewis Antwi.

Example Report

Lewis Antwi FDA InspectorProfile Overview Example
Lewis Antwi FDA InspectorProfile Metrics Example
Lewis Antwi FDA InspectorProfile Citations Example
Lewis Antwi FDA InspectorProfile Inspections List
Add To Cart13 of Antwi 483s in stock

Product details

  • Lewis Antwi's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Lewis Antwi has conducted including:

Note: The EIR and 483 documents are sold separately.

Add To Cart13 of Lewis's 483s Available Now.